Abstract: The present invention provides an antifouling ability-imparting agent that adheres well to a variety of water treatment membranes such as reverse osmosis membranes and imparts excellent antifouling ability to the water treatment membranes.

Abstract: A superconducting coil device according to one embodiment of the present invention includes: A superconducting coil device including: a bobbin having a tubular body; superconducting wires, a part of which constitutes a wound portion where the superconducting wires are wound on the bobbin; a bobbin-side guide portion holding the superconducting wires extending from the bobbin, the bobbin-side guide portion being provided to extend in a bobbin axial direction, which is an axial direction of the body of the bobbin; a first guide portion holding the superconducting wires extending from the bobbin-side guide portion, the first guide portion being arranged on an outer side of the bobbin-side guide portion in a direction intersecting the bobbin axial direction and provided to extend in the direction intersecting the bobbin axial direction; and a second guide portion capable of holding the superconducting wires extending from the first guide portion, the second guide portion being provided to extend in a direction in

Abstract: The present invention provides an antifouling ability-imparting agent that adheres well to a variety of water treatment membranes such as reverse osmosis membranes and imparts excellent antifouling ability to the water treatment membranes.

Abstract: A medical image diagnosis apparatus for use in a therapeutic procedure to a subject includes processing circuitry. The processing circuitry is configured to determine a status of a current therapeutic procedure; determine at least one proposed preset of settings of the medical image diagnosis apparatus according to the status of the current therapeutic procedure; and perform a control in accordance with the at least one proposed preset.

Abstract: A medical data managing apparatus includes processing circuitry. The processing circuitry generates network access data based on patient information of a patient. The processing circuitry acquires the reference data from a data generating device via a communication network constructed based on the network access data, and checks the reference data against benchmark data included in the patient information. The processing circuitry acquires, when it is determined that the reference data and the benchmark data represent same patient as a result of the check, the multiple non-DICOM data from the data generating device via the constructed communication network. The processing circuitry classifies each of the multiple non-DICOM data into first non-DICOM data to be registered in a data archive apparatus or other second non-DICOM data, and displays the first non-DICOM data and the second non-DICOM data on a display in different display modes.

Abstract: The medical image diagnostic apparatus according to an embodiment includes processing circuitry. The processing circuitry is configured to: generate medical volume data including bones and an organ; identify, based on the volume data, the organ and an abnormal bone having an abnormal region of the bones; calculate, based on the organ and the abnormal bone of the volume data, an influence rate on the organ by the abnormal bone; and superimpose data indicating the influence rate on the image based on the volume data, thereby displaying the superimposed image on a display.

Abstract: According to one embodiment, a schema storage unit stores a reference schema that schematically expresses the internal structure of a diagnosis target blood vessel concerning the reference section of the diagnosis target blood vessel. A schema processing unit automatically generates a schema concerning a section crossing the reference section of the diagnosis target blood vessel by image processing based on the reference schema.

Abstract: The medical image diagnostic apparatus according to an embodiment includes processing circuitry. The processing circuitry is configured to: generate medical volume data including bones and an organ; identify, based on the volume data, the organ and an abnormal bone having an abnormal region of the bones; calculate, based on the organ and the abnormal bone of the volume data, an influence rate on the organ by the abnormal bone; and superimpose data indicating the influence rate on the image based on the volume data, thereby displaying the superimposed image on a display.

Abstract: The medical data managing apparatus according to the present embodiment includes processing circuitry. The processing circuitry generates network access data based on patient information of a patient. The processing circuitry acquires the reference data from a data generating device via a communication network constructed based on the network access data, and checks the reference data against benchmark data included in the patient information. The processing circuitry acquires, when it is determined that the reference data and the benchmark data represent same patient as a result of the check, the multiple non-DICOM data from the data generating device via the constructed communication network. The processing circuitry classifies each of the multiple non-DICOM data into first non-DICOM data to be registered in a data archive apparatus or other second non-DICOM data, and displays the first non-DICOM data and the second non-DICOM data on a display so as to be recognizable from each other.

Abstract: The present invention provides a method for producing a fluorisulfonylimide salt, which enables reducing the impurity content and continuous operation for a long time, and a fluorosulfonyl imide salt. The fluorosulfonyl imide salt of the present invention has a K content of 10,000 ppm or less. The method for producing a fluorosulfonyl imide salt of the present invention is that after a fluorination reaction of chlorosulfonyl imde or a salt thereof, the reaction solution is brought into contact with an aqueous alkaline solution so as to remove impurities. The fluorosulfonyl imide salt of the present invention, in which various impirities are reduced to extremely low levels, is useful as an electrolyte used in a lithium secondary battery, a capacitor or the like, an ionic liquid, or an intermediate for a sulfonyl imide salt, and the like. It is expected that use of the fluorosulfonyl imide salt of the present invention as an electrolyte leads to a high-performance electrochemical device.

Abstract: The present invention provides an ionic compound containing a cyanoborate; a process for production thereof; and an electrolytic solution and a device. The electrolytic solution comprises an ionic compound represented by general formula (1) and a solvent, Mn+([B(CN)4-mYm]?)n??(1) wherein Mn+ represents an organic or inorganic cation having a valency of 1 to 3; Y represents a halogen, a hydrocarbon group which has a main chain having 1 to 10 carbon atoms and which may optionally contain a halogen, —C(O)R14, —S(O)lR14, —Z(R14)2, or —XR14; R14 represents H, a halogen, or an organic substituent group which has a main chain having 1 to 10 atoms; Z represents N or P; X represents O or S; R13 represents H, or an hydrocarbon group which has a main chain having 1 to 10 atoms; l represents an integer of 1 to 2; m and n represent an integer of 1 to 3 respectively.

Abstract: According to one embodiment, a schema storage unit stores a reference schema that schematically expresses the internal structure of a diagnosis target blood vessel concerning the reference section of the diagnosis target blood vessel. A schema processing unit automatically generates a schema concerning a section crossing the reference section of the diagnosis target blood vessel by image processing based on the reference schema.

Abstract: The present invention provides an ionic compound containing a cyanoborate; a process for production thereof; and an electrolytic solution and a device, each utilizing the ionic compound. The electrolytic solution of the present invention comprises an ionic compound represented by general formula (1) and a solvent. Further, a production process of the present invention comprises reacting a compound represented by general formula (8) with a substitution reaction reagent to obtain a compound represented by general formula (1).

Abstract: The present invention provides a method for producing a fluorisulfonylimide salt, which enables reducing the impurity content and continuous operation for a long time, and a fluorosulfonyl imide salt. The fluorosulfonyl imide salt of the present invention has a K content of 10,000 ppm or less. The method for producing a fluorosulfonyl imide salt of the present invention is that after a fluorination reaction of chlorosulfonyl imde or a salt thereof, the reaction solution is brought into contact with an aqueous alkaline solution so as to remove impurities. The fluorosulfonyl imide salt of the present invention, in which various impirities are reduced to extremely low levels, is useful as an electrolyte used in a lithium secondary battery, a capacitor or the like, an ionic liquid, or an intermediate for a sulfonyl imide salt, and the like. It is expected that use of the fluorosulfonyl imide salt of the present invention as an electrolyte leads to a high-performance electrochemical device.